NCT03543462 (DRAGON) is a Phase 4 clinical trial of thoracic Drain Tube 24 Fr. in Ovarian Cancer, sponsored by Catholic University of the Sacred Heart.

Who is sponsoring NCT03543462?

NCT03543462 is sponsored by Catholic University of the Sacred Heart.

What drugs are being tested in NCT03543462?

Interventions in NCT03543462: thoracic Drain Tube 24 Fr..

What condition does NCT03543462 study?

NCT03543462 studies Ovarian Cancer.

Is NCT03543462 still recruiting?

NCT03543462 is currently completed. Last updated 22 May 2020.

Last reviewed 2020-05-22 · How we verify

NCT03543462: DRAGON

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diaphragmatic Resection And Gynecological Ovarian Neoplasm

Completed Phase 4 Last updated 22 May 2020

What this trial tests

Phase 4 trial testing thoracic Drain Tube 24 Fr. in Ovarian Cancer in 88 participants. Completed in 11 January 2020.

Timeline

20 March 2018

Primary endpoint
11 November 2019

11 January 2020

Quick facts

Lead sponsor	Catholic University of the Sacred Heart
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	88
Start date	20 March 2018
Primary completion	11 November 2019
Estimated completion	11 January 2020
Sites	1 location across Italy

Drugs / interventions tested

thoracic Drain Tube 24 Fr.

Conditions studied

Ovarian Cancer — all drugs for Ovarian Cancer →

Sponsor

Catholic University of the Sacred Heart

Who can join

Adults 18 to 80, female only, with Ovarian Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective randomized phase IV study aimed to value the impact of diaphragmatic surgery and the useful of intra-operatory thoracic drain in advanced ovarian cancer. Considering the fact that the diaphragmatic surgery could contribute with the incidence of post-operatory morbidity. The study is aimed to value the role of thoracic drain in post-operative outcomes as hospital stay, time to chemotherapy, drugs use and eventual interventions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ovarian Cancer

Currently open trials in the same condition.

NCT06412120 — Study Evaluating Safety, Tolerability, and Metabolism of Niraparib · Phase 4 · recruiting
NCT06930755 — Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer · Phase 1 · recruiting
NCT07318558 — A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · Phase 3 · recruiting
NCT07491081 — EARLY Study: Evaluating the Specificity and Feasibility of the EARLY Biomarker Panel for Ovarian Cancer Detection · NA · recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting

Other Catholic University of the Sacred Heart trials

Trials by the same sponsor.

NCT07476599 — The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Ob · NA · not yet recruiting
NCT07516392 — Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma · NA · not yet recruiting
NCT07140705 — Personalized Virtual Reality for Promoting Well-Being and Psychological Flexibility in General Practitioners · NA · completed
NCT06992453 — Multi-omics Dissection of Gut Microbiome Engraftment During FMT · NA · not yet recruiting
NCT06852183 — Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03543462 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catholic University of the Sacred Heart
Last refreshed: 22 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03543462.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing